Table 1.
Men | Women | |||
---|---|---|---|---|
OR (95 % CI) | P value | OR (95 % CI) | P value | |
unadjusted | 1.08 (0.70–1.68) | 0.737 | 1.38 (1.04–1.85) | 0.028 |
Model 1 | 0.96 (0.73–1.57) | 0.596 | 1.25 (1.02–1.69) | 0.031 |
Model 2 | 0.87 (0.68–1.44) | 0.264 | 1.20 (1.02–1.57) | 0.034 |
Model 3 | 1.00 (0.74–1.36) | 0.986 | 1.23 (1.09–1.45) | 0.038 |
Model 4 | 1.00 (0.73–1.36) | 0.991 | 1.21 (1.11–1.42) | 0.038 |
Model 5 | 1.01 (0.75–1.61) | 0.784 | 1.18 (1.13–1.39) | 0.039 |
Model 6 | 1.20 (1.11–1.53) | 0.040 |
We defined participants without osteoporotic fractures as 0 and those with osteoporotic fractures as 1. Model 1 was adjusted for age, smoking and alcohol consumption habits (yes/no), physical activity (MET-h/wk), and eGFR. Model 2 was further adjusted for BMI, waist circumference and hip circumference based on model 1. Model 3 was further adjusted for serum TG, TC, HDL-c, and LDL-c based on model 2. Model 4 was further adjusted for diabetes status (yes/no), FPG and HbA1c based on model 3. Model5 was further adjusted for blood pressure on model 4. Model 6 was further adjusted for menopause status (yes/no) and hormone replacement (yes/no) treatment for women based on model 5